PPMI News

The Parkinson's Progression Markers Initiative is our landmark study launched in 2010 to deepen knowledge of Parkinson's and to better understand its onset and progression to speed the development of new treatments. Learn the latest news from the study here.

Ask the MD: Parkinson's Diagnosis and Biomarkers

March 22, 2018

In the latest “Ask the MD” video, Dr. Dolhun talks about how doctors diagnose Parkinson’s and how a tool called a biomarker may help.

Learn more
Parkinson's Protein Levels Stable over Year in Early Disease

October 13, 2017

Analysis from the MJFF-led PPMI points to potential use of these biomarkers for testing drug engagement but likely not for tracking short-term progression.

Learn more
PPMI Data Shows Brain Changes Linked to Parkinson's Progression

August 2, 2017

Two studies using data from the MJFF-led Parkinson's Progression Markers Initiative point to brain imaging scans that could help advance drug trials.

Learn more
Palfreman: Toward Parkinson's Personalized Medicine

May 8, 2017

In his latest blog post for the Journal of Parkinson's Disease, science journalist and person with Parkinson's Jon Palfreman introduces us to Personalized Parkinson Project.

Learn more
Study Reveals Risk Factors for Early Psychosis in Parkinson's

April 18, 2017

A recent study using data from PPMI has identified risk factors that may predict the development of early psychosis in Parkinson's.

Learn more
2016 PPMI Data Challenge Winning Submissions Webinar

February 24, 2017

Winners of the 2016 PPMI Data Challenge from UC San Francisco and Weill Cornell Medicine will review their methods and findings and will answer questions from the audience.

Learn more
2016 PPMI Data Challenge Winners Outline Parkinson's Progression Predictors and Subtypes

November 29, 2016

Tools developed by the winners from UC San Francisco and Weill Cornell Medicine could accelerate testing of new Parkinson's treatments by helping researchers design trials and choose study…

Learn more